KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Other financing activities (2017 - 2025)

Historic Other financing activities for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to $12000.0.

  • Cardlytics' Other financing activities fell 9552.24% to $12000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $306000.0, marking a year-over-year decrease of 9475.67%. This contributed to the annual value of $6.0 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Cardlytics' Other financing activities stood at $12000.0, which was down 9552.24% from $59000.0 recorded in Q2 2025.
  • Cardlytics' 5-year Other financing activities high stood at $5.3 million for Q2 2024, and its period low was -$45000.0 during Q3 2023.
  • Over the past 5 years, Cardlytics' median Other financing activities value was $38000.0 (recorded in 2021), while the average stood at $407250.0.
  • As far as peak fluctuations go, Cardlytics' Other financing activities plummeted by 74285.71% in 2023, and later soared by 1766333.33% in 2024.
  • Cardlytics' Other financing activities (Quarter) stood at $10000.0 in 2021, then plummeted by 170.0% to -$7000.0 in 2022, then tumbled by 542.86% to -$45000.0 in 2023, then soared by 546.67% to $201000.0 in 2024, then tumbled by 94.03% to $12000.0 in 2025.
  • Its last three reported values are $12000.0 in Q3 2025, $59000.0 for Q2 2025, and $34000.0 during Q1 2025.